Clarification from the Company

SHUKRA PHARMACEUTICALS LTD. Date: October 6,2026 The Manager, Surveillance Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001 Scrip Codez 524632 Ref: Email letter no. L/SURV/ONL/PV/SJ/2026-202714349 dated October 06,2026 Sub: Clarification on Price Movement Dear Sir / Madam, This has reference to your email dated October 6, 2026, seeking clarification on the significant movement in the price of our security at the Exchange in the recent past. In this regard, we wish to clarif, and confirm that Shukra Pharmaceuticals Ltd is fully compliant with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has been regularly intimating the Exchange of all events, infonnation, and corporate actions that have a bearing on the operations, performance, or price behavior of our scrip in a timely manner. We wish to state that there is no undisclosed, price-sensitive information, or any impending announcement/corporate event that, in our opinion, needs to be shared with the investors at this stage. The recent movement in the share price of the Company is purely market-driven and a result of natural market forces. The management of the Company is in no way corulected with such price movement. We request you to kindly take the above clarification on your records and oblige. Thanking you, Yours faithfully, For Shukra Pharmaceuticals Ltd Name: Shivkant Dhakad Company Secretary & Compliance Officer ACS no. A80894 Cl N : L2423rG11993 PtC0t9079 Regd. Office : 3rd Floor, "VEER HOUSE" Opp. WIM Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 3g0 054. Factory 104..: 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar -3Il72l,Gujarat, lndia, ph. :02764-2g6317 trmril ' inf^/ich,,t .-^h^.-^^^,,*-^r-